Skip to main content
. 2020 Oct 31;98(6):1568–1577. doi: 10.1016/j.kint.2020.10.008

Table 2.

Evolution of the characteristics of renal transplant recipients and candidates over the past 3 years

Recipients
P Candidates
P Pa
2018 2019 2020 2018 2019 2020
N 39,865 41,210 42,812 14,418 15,289 16,210
Male 24,694 (61.9) 25,463 (61.8) 26,474 (61.8) 0.90 8856 (61.4) 9468 (61.9) 10,112 (62.4) 0.23 0.23
Age, yr 56.1 ± 14.9 56.5 ± 15 57.0 ± 15 <0.001 55.9 ± 13.9 56.8 ± 13.8 57.5 ± 13.9 <0.001 <0.01
Cardiovascular disease 3131 (14.1) 3355 (13.7) 3635 (13.6) 0.21 2480 (18.4) 2698 (18.7) 2876 (18.8) 0.74 <0.01
Diabetes 4687 (19.5) 5033 (19.2) 5437 (19.1) 0.47 3906 (28.3) 4300 (29.1) 4756 (30.3) <0.001 <0.01
BMI, kg/m2 25.7 ± 5.2 25.7 ± 5.2 25.8 ± 5.2 0.09 26.1 ± 5.4 26.2 ± 5.3 26.2 ± 5.3 0.11 <0.01
Blood group 0.93 0.68 <0.01
 A 17,430 (43.7) 17,941 (43.6) 18,559 (43.4) 4714 (32.7) 4997 (32.7) 5354 (33)
 B 1715 (4.3) 1791 (4.3) 1898 (4.4) 490 (3.4) 539 (3.5) 541 (3.3)
 AB 4284 (10.8) 4419 (10.7) 4639 (10.8) 2064 (14.3) 2270 (14.8) 2399 (14.8)
 O 16,418 (41.2) 17,041 (41.4) 17,698 (41.4) 7150 (49.6) 7483 (48.9) 7916 (48.8)
Cause of ESRD 0.23 0.08 <0.01
 Diabetes 3102 (7.8) 3247 (7.9) 3452 (8.1) 2357 (16.4) 2534 (16.6) 2697 (16.6)
 Glomerulonephritis 10,252 (25.7) 10,508 (25.5) 10,801 (25.2) 2918 (20.2) 3031 (19.8) 3176 (19.6)
 Nephroangiosclerosis 2351 (5.9) 2505 (6.1) 2690 (6.3) 1538 (10.7) 1696 (11.1) 1940 (12)
 Other 10,574 (26.5) 10,885 (26.4) 11,302 (26.4) 3791 (26.3) 4054 (26.5) 4248 (26.2)
 Polycystic kidney disease 6295 (15.8) 6598 (16) 6910 (16.1) 1830 (12.7) 1896 (12.4) 1962 (12.1)
 Tubulointerstitial nephritis 7291 (18.3) 7464 (18.1) 7654 (17.9) 1981 (13.7) 2076 (13.6) 2185 (13.5)
Previous transplantation 5270 (13.2) 5438 (13.2) 5576 (13) 0.67 3269 (22.7) 3311 (21.7) 3467 (21.4) 0.02 <0.01
Time since transplantation, mo 110.4 ± 92.9 112.1 ± 94.2 114.2 ± 95.7 <0.001
Last eGFR MDRD, ml/min 52.8 ± 22.1 53 ± 22.4 52.3 ± 22.7 <0.001
Time on dialysis, mo 35.4 ± 48.4 35.1 ± 47.6 34.9 ± 46.7 0.25 40.5 ± 54.7 40.3 ± 53.5 40.6 ± 54.2 0.90 <0.01

BMI, body mass index; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal disease; MDRD, Modification of Diet in Renal Disease.

Values are n (%) or mean (± SD), unless otherwise indicated.

a

The P values for the comparison of the clinical characteristics of recipients and candidates in 2020.